Green Cross Files for Peramivir Regulatory Approval in South Korea

BioCryst Pharmaceuticals, Inc. announced that it has been informed by its partner, Green Cross Corp., that Green Cross has filed a New Drug Application in South Korea to seek regulatory approval for intravenous peramivir to treat patients with influenza.
SunHerald